TGF-BETa 2 antisense ISTH0036 for the Treatment of diabetic macular Edema (DME) and neovascular age-related maculaR degeneration (nAMD) The “BETTER” Study

  • Casazza, Marina (Researcher)
  • Donner, Nadine (Researcher)
  • Eidherr, Markus (Researcher)
  • Gärtner, Michaela (Researcher)
  • Kallab, Martin (Researcher)
  • Khalil, Haidar (Researcher)
  • Kicsak, Henriet (Researcher)
  • Laubichler, Peter (Researcher)
  • Mariacher, Siegfried (Researcher)
  • Murauer, Olivia (Researcher)
  • Pomberger, Leon Julian (Researcher)
  • Schneider, Sophie (Researcher)
  • Silber, Christina (Researcher)
  • Siska, René (Researcher)
  • Strauß, Rupert (Researcher)
  • Waser, Klemens (Researcher)
  • Wesely, Ingrid (Researcher)
  • Bolz, Matthias (PI)

Project: Clinical studies › Clinical Study (Industry project)

Project Details

Description

TGF-BETa 2 antisense ISTH0036 for the Treatment of diabetic macular Edema (DME) and neovascular age-related maculaR degeneration (nAMD)
StatusFinished
Effective start/end date03.08.2021 → 01.03.2024

Fields of science

  • 302007 Ophthalmology